Mayer, M.; Nachtsheim, L.; Hoffmann, F.; von Eggeling, F.; Guntinas-Lichius, O.; Prinz, J.; Klußmann, J.P.; Quaas, A.; Arolt, C.; Wolber, P.
CD138 Is Expressed in Different Entities of Salivary Gland Cancer and Their Lymph Node Metastases and Therefore Represents a Potential Therapeutic Target. Int. J. Mol. Sci. 2022, 23, 9037.
https://doi.org/10.3390/ijms23169037
AMA Style
Mayer M, Nachtsheim L, Hoffmann F, von Eggeling F, Guntinas-Lichius O, Prinz J, Klußmann JP, Quaas A, Arolt C, Wolber P.
CD138 Is Expressed in Different Entities of Salivary Gland Cancer and Their Lymph Node Metastases and Therefore Represents a Potential Therapeutic Target. International Journal of Molecular Sciences. 2022; 23(16):9037.
https://doi.org/10.3390/ijms23169037
Chicago/Turabian Style
Mayer, Marcel, Lisa Nachtsheim, Franziska Hoffmann, Ferdinand von Eggeling, Orlando Guntinas-Lichius, Johanna Prinz, Jens Peter Klußmann, Alexander Quaas, Christoph Arolt, and Philipp Wolber.
2022. "CD138 Is Expressed in Different Entities of Salivary Gland Cancer and Their Lymph Node Metastases and Therefore Represents a Potential Therapeutic Target" International Journal of Molecular Sciences 23, no. 16: 9037.
https://doi.org/10.3390/ijms23169037
APA Style
Mayer, M., Nachtsheim, L., Hoffmann, F., von Eggeling, F., Guntinas-Lichius, O., Prinz, J., Klußmann, J. P., Quaas, A., Arolt, C., & Wolber, P.
(2022). CD138 Is Expressed in Different Entities of Salivary Gland Cancer and Their Lymph Node Metastases and Therefore Represents a Potential Therapeutic Target. International Journal of Molecular Sciences, 23(16), 9037.
https://doi.org/10.3390/ijms23169037
